Skip to content

Effect of Laughter Yoga on Menopausal Symptoms, Sleep, and Quality of Life in Menopausal Women

Evaluation of the Effects of Laughter Yoga on Menopausal Symptoms, Sleep, and Quality of Life in Menopausal Women

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07435545
Enrollment
80
Registered
2026-02-27
Start date
2026-03-01
Completion date
2026-03-29
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause

Keywords

Laughter Yoga, Menopause, Menopausal Symptoms, Sleep Quality, Quality of Life, Non-Pharmacological Intervention, Women's Health, Menopausal Women

Brief summary

This study aims to provide meaningful contributions to both academic literature and clinical nursing practice by examining laughter yoga, a non-pharmacological, evidence-based, and feasible intervention for quality of life and sleep problems commonly encountered during menopause. Menopause is a natural stage of life that can be associated with physical and psychological symptoms affecting daily life. Laughter yoga, a group-based complementary method, is based on the philosophy that "movement creates emotion" and aims to transform voluntary laughter into natural and genuine laughter over time. Laughter yoga consists of clapping and warm-up exercises, childlike games, deep breathing techniques, laughter exercises, and meditation stages. Thanks to its physiological and psychological effects, it supports individuals' overall well-being. In this study, participants will be divided into two groups: an intervention group and a control group. A pre-test will be administered to both groups to assess menopause symptoms, sleep quality, and quality of life. The intervention group will undergo eight sessions of laughter yoga, while the control group will not receive any intervention during the study period. A post-test will be administered to both groups after the intervention to evaluate its effectiveness. The results of the study are expected to contribute to determining whether laughter yoga is an effective supportive approach during menopause. It is particularly important in terms of establishing a scientific basis for the integration of complementary treatment approaches into the menopause period and ensuring that they can be integrated with nursing care.

Detailed description

This study is designed as a controlled trial involving women in the menopause period, with participants individually randomized using a simple randomization method. The study will be conducted at a family health center affiliated with the Mamak Cultural Center Coordination in Ankara, Turkey. Eligible participants will be randomly assigned to either the laughter yoga intervention group or the control group at a 1:1 ratio using a computer-generated randomization sequence. Following the pre-test, the intervention group will receive a total of eight laughter yoga sessions over four weeks, twice a week. No intervention will be administered to the control group during the study period. Menopause symptoms, sleep quality, and menopause-specific quality of life will be assessed using pre-test and post-test measurements. This study aims to determine the effect of laughter yoga on changes experienced during menopause and on sleep and quality of life.

Interventions

BEHAVIORALLaughter Yoga

The intervention consists of a total of 8 laughter yoga sessions, with 2 sessions per week for four weeks. Each laughter yoga session is planned to last an average of 20 minutes. Each session will begin with clapping and warm-up exercises and continue with childlike games, deep breathing exercises, and laughter exercises. It will end with meditation. It is a group-based practice, and the aim is to increase psychosocial well-being by transforming fake laughter into real laughter and to benefit from the physiological effects of laughter.

Sponsors

Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

Participants will not know which group they belong to. Laughter yoga will be administered to the experimental group on the day of the final test. By having both groups receive laughter yoga, participants will be prevented from knowing which group they belong to, thereby reducing the possibility of bias.

Intervention model description

Participants will be randomly assigned to two groups: the intervention group and the control group. A pre-test will be conducted to assess menopause symptoms, sleep quality, and quality of life. While the intervention group will receive eight sessions of laughter yoga, the control group will not receive any intervention during the study period. A final test will be conducted in both groups to assess changes in menopause symptoms, sleep quality, and quality of life. After the final assessments are completed, the control group will also receive the laughter yoga intervention.

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Being in the menopause period * Having sufficient proficiency in understanding and expressing oneself in Turkish * Agreeing to participate in the study * Having physical and cognitive competence * Not having a diagnosis of mental disorder * Not using hormone therapy or complementary treatments for menopause symptoms

Exclusion criteria

* Not participating in laughter yoga sessions * Withdrawing from the study during the research phase * Incomplete filling out of data collection forms * Having contraindications for laughter yoga (Bleeding hemorrhoids, psychiatric disorders, epilepsy, undergoing surgery within the last 3 months, and similar conditions)

Design outcomes

Primary

MeasureTime frameDescription
Change in Menopausal SymptomsBaseline and immediately after the 4-week interventionMenopause symptoms will be assessed using the Menopause Rating Scale (MRS). Changes in total MRS scores from baseline to post-intervention will be compared between the intervention group and the control group.

Secondary

MeasureTime frameDescription
Change in Sleep QualityBaseline and immediately after the 4-week interventionSleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). Changes in PSQI scores at baseline and after the 4-week intervention will be compared between groups.
Change in Menopause-Specific Quality of LifeBaseline and immediately after the 4-week interventionQuality of life will be assessed using the Menopause-Specific Quality of Life Questionnaire (MENQOL). Changes in MENQOL scores at baseline and after the 4-week intervention will be compared between the intervention and control groups.

Countries

Turkey (Türkiye)

Contacts

CONTACTDerya UZUNCA, BSc, RN
deryauzunca673@gmail.com+905071720400
CONTACTProf. Dr. Gülten Güvenç, PhD
gulten.guvenc@sbu.edu.tr
PRINCIPAL_INVESTIGATORProf.Dr. Gülten Güvenç, PhD

Saglik Bilimleri Universitesi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026